Latest Breaking News On - Tony adamis - Page 1 : comparemela.com

Merck acquires EyeBio in up to $3B deal

Merck & Co Inc (NYSE:MRK, ETR:6MK) announced it is acquiring Eyebio, a privately held ophthalmology-focused biotech firm, in a deal valued up to $3 billion..

Merck eyes purchase of ophthalmology company

In addition to augmenting Merck’s pipeline, the company said, the acquisition significantly expands the company’s presence in ophthalmology.

Dame Kate Bingham Celebrates 'Astonishing' $3bn Deal for EyeBio

London-based biotech company EyeBio, co-founded by Dame Kate Bingham, sold to Merck for up to $3bn, promising revolutionary treatments for blindness.

Merck to Acquire EyeBio

Jeito Capital announces the acquisition by Merck & Co (NYSE: MRK) of its portfolio company EyeBio for a potential value of $3 billion

Jeito Capital announces the acquisition by Merck & Co (NYSE: MRK)of its portfolio company EyeBio for a potential value of $3 billion This acquisition reflects the significant clinical progress